JP2003524387A5 - - Google Patents

Download PDF

Info

Publication number
JP2003524387A5
JP2003524387A5 JP2000585407A JP2000585407A JP2003524387A5 JP 2003524387 A5 JP2003524387 A5 JP 2003524387A5 JP 2000585407 A JP2000585407 A JP 2000585407A JP 2000585407 A JP2000585407 A JP 2000585407A JP 2003524387 A5 JP2003524387 A5 JP 2003524387A5
Authority
JP
Japan
Prior art keywords
pro323
sequence
dna
full
length
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2000585407A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003524387A (ja
Filing date
Publication date
Priority claimed from PCT/US1998/025108 external-priority patent/WO1999028462A2/en
Application filed filed Critical
Priority claimed from PCT/US1999/028301 external-priority patent/WO2000032776A2/en
Publication of JP2003524387A publication Critical patent/JP2003524387A/ja
Publication of JP2003524387A5 publication Critical patent/JP2003524387A5/ja
Withdrawn legal-status Critical Current

Links

JP2000585407A 1998-12-01 1999-12-01 分泌及び膜貫通ポリペプチドとそれをコードする核酸 Withdrawn JP2003524387A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
PCT/US1998/025108 WO1999028462A2 (en) 1997-12-03 1998-12-01 Polypeptides and nucleic acids encoding the same
US11285098P 1998-12-16 1998-12-16
US11329698P 1998-12-22 1998-12-22
US60/113,296 1999-07-26
US60/112,850 1999-07-26
US9825108 1999-07-26
PCT/US1999/028301 WO2000032776A2 (en) 1998-12-01 1999-12-01 Secreted amd transmembrane polypeptides and nucleic acids encoding the same

Publications (2)

Publication Number Publication Date
JP2003524387A JP2003524387A (ja) 2003-08-19
JP2003524387A5 true JP2003524387A5 (https=) 2004-12-24

Family

ID=33459268

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000585407A Withdrawn JP2003524387A (ja) 1998-12-01 1999-12-01 分泌及び膜貫通ポリペプチドとそれをコードする核酸

Country Status (8)

Country Link
US (1) US20040235109A1 (https=)
EP (1) EP1135495A2 (https=)
JP (1) JP2003524387A (https=)
KR (1) KR20010081111A (https=)
AU (1) AU2474700A (https=)
CA (1) CA2347677A1 (https=)
MX (1) MXPA01005425A (https=)
WO (1) WO2000032776A2 (https=)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7217788B2 (en) 1996-03-14 2007-05-15 Human Genome Sciences, Inc. Human tumor necrosis factor delta polypeptides
US6541224B2 (en) 1996-03-14 2003-04-01 Human Genome Sciences, Inc. Tumor necrosis factor delta polypeptides
NZ510356A (en) 1998-08-07 2004-12-24 Immunex Corp Molecules designated LDCAM
JP3964678B2 (ja) 1999-10-28 2007-08-22 アジェンシス，インコーポレイテッド ３６ｐ６ｄ５：分泌腫瘍抗原
AU2001281254A1 (en) * 2000-08-10 2002-02-18 Pharmacia Corporation A new egf motif repeat protein obtained from a cdna library from hs-5 stromal cell line
JP2004537290A (ja) 2001-05-24 2004-12-16 ヒューマン　ジノーム　サイエンシーズ，　インコーポレイテッド 腫瘍壊死因子δ（ＡＰＲＩＬ）に対する抗体
WO2003029467A1 (fr) * 2001-09-05 2003-04-10 Japan Science And Technology Corporation Candidate proteine pour nouveau facteur de polarisation cellulaire et polynucleotide codant cette proteine
AU2003230759A1 (en) * 2002-04-03 2003-10-20 Syngenta Participations Ag Detection of wheat and barley fungal pathogens which are resistant to certain fungicides using the polymerase chain reaction
EP1648935A2 (en) 2003-07-25 2006-04-26 Amgen Inc. Antagonists and agonists of ldcam and methods of use
US20050186577A1 (en) 2004-02-20 2005-08-25 Yixin Wang Breast cancer prognostics
ES2625259T3 (es) 2006-08-29 2017-07-19 Oxford Biotherapeutics Ltd Identificación de proteína asociada con carcinoma hepatocelular, glioblastoma y cáncer de pulmón
US8420084B2 (en) 2009-03-05 2013-04-16 Medarex, Inc. Fully human antibodies specific to CADM1
US20180133252A9 (en) 2014-09-09 2018-05-17 Unum Therapeutics Inc. Chimeric receptors and uses thereof in immune therapy
CN105384825B (zh) 2015-08-11 2018-06-01 南京传奇生物科技有限公司 一种基于单域抗体的双特异性嵌合抗原受体及其应用
EP4282877A3 (en) 2016-08-10 2024-02-21 Legend Biotech Ireland Limited Chimeric antigen receptors targeting bcma and methods of use thereof
CA3104862A1 (en) 2018-07-03 2020-01-09 Sotio, LLC Chimeric receptors in combination with trans metabolism molecules enhancing glucose import and therapeutic uses thereof
KR20210045418A (ko) 2018-08-14 2021-04-26 소티오, 엘엘씨 크렙스 사이클을 조정하는 트랜스 대사 분자와 조합된 키메라 항원 수용체 폴리펩타이드 및 이의 치료적 용도
US12097219B2 (en) 2018-09-10 2024-09-24 Legend Biotech Ireland Limited Single-domain antibodies against CLL1 and constructs thereof
WO2020092057A1 (en) 2018-10-30 2020-05-07 Yale University Compositions and methods for rapid and modular generation of chimeric antigen receptor t cells
US11981932B2 (en) 2020-06-17 2024-05-14 Janssen Biotech, Inc. Materials and methods for the manufacture of pluripotent stem cells
JP7846667B2 (ja) 2020-07-16 2026-04-15 レジェンド バイオテック アイルランド リミテッド Ｃｄ２０結合分子及びその使用
US20230174651A1 (en) 2021-06-23 2023-06-08 Janssen Biotech, Inc. Materials and methods for hinge regions in functional exogenous receptors
WO2023049933A1 (en) 2021-09-27 2023-03-30 Sotio Biotech Inc. Chimeric receptor polypeptides in combination with trans metabolism molecules that re-direct glucose metabolites out of the glycolysis pathway and therapeutic uses thereof
WO2023173137A1 (en) 2022-03-11 2023-09-14 Yale University Compositions and methods for efficient and stable genetic modification of eukaryotic cells
US20250161360A1 (en) 2022-05-10 2025-05-22 Yale University Compositions and methods of synthetic ctla-4 tails for reprogramming of car-t cells and enhancement of anti-tumor efficacy
CA3262611A1 (en) 2022-07-22 2024-01-25 Janssen Biotech, Inc. IMPROVED TRANSFER OF GENETIC INSTRUCTIONS TO EFFECTOR IMMUNE CELLS
US20260053924A1 (en) 2022-08-19 2026-02-26 Sotio Biotech Inc. Genetically engineered immune cells with chimeric receptor polypeptides in combination with multiple trans metabolism molecules and therapeutic uses thereof
WO2024040207A1 (en) 2022-08-19 2024-02-22 Sotio Biotech Inc. Genetically engineered natural killer (nk) cells with chimeric receptor polypeptides in combination with trans metabolism molecules and therapeutic uses thereof
WO2024064824A2 (en) 2022-09-21 2024-03-28 Yale University Compositions and methods for identification of membrane targets for enhancement of nk cell therapy
WO2024155821A1 (en) 2023-01-18 2024-07-25 Yale University Chimeric antigen receptors (car) with intrinsically disordered regions and methods of use thereof
WO2024215987A1 (en) 2023-04-14 2024-10-17 Sotio Biotech Inc. IMMUNE CELLS FOR TREATING CANCER IN COMBINATION WITH IL-15/IL-15Rα CONJUGATES
EP4694916A1 (en) 2023-04-14 2026-02-18 SOTIO Biotech Inc. Engineered immune cells for treating cancer in combination with il-2/il-15 receptor ?? agonists
WO2024226829A2 (en) 2023-04-26 2024-10-31 Yale University Enpp3-binding molecules, compositions formed therefrom, and methods of use thereof for the treatment of cancer
EP4713352A1 (en) 2023-05-15 2026-03-25 Yale University Chimeric antigen receptor compositions, car-mast cells formed therefrom, and methods of use thereof
AU2024277678A1 (en) 2023-05-25 2025-11-27 Dispatch Biotherapeutics, Inc. Synthetic cancer antigens as targets for treating cancers
WO2025158400A1 (en) 2024-01-24 2025-07-31 Yale University Compositions and methods of natural killer cell hyperboosts for enhancement of nk cell therapy
WO2025171388A1 (en) 2024-02-09 2025-08-14 Dispatch Biotherapeutics, Inc. Engineered cancer antigens with modified domains and related methods and uses
WO2025245381A1 (en) 2024-05-23 2025-11-27 The Trustrees Of Dartmouth College Methods and compositions for enhancing the persistence of car expressing tregs in the cns and other tissues

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5707829A (en) * 1995-08-11 1998-01-13 Genetics Institute, Inc. DNA sequences and secreted proteins encoded thereby
US5824504A (en) * 1996-09-26 1998-10-20 Elshourbagy; Nabil A. Human 7-transmembrane receptor and DNA
CA2311640A1 (en) * 1997-12-03 1999-06-10 Genentech, Inc. Polypeptides and nucleic acids encoding the same
JP2002511259A (ja) * 1998-04-09 2002-04-16 ジェンセット ５’ｅｓｔおよびコードされるヒトタンパク質

Similar Documents

Publication Publication Date Title
JP2003524387A5 (https=)
JP2004522402A5 (https=)
JP2003529317A5 (https=)
DK2627773T3 (en) MOUSE WITH LIMITED IMMUNOGLOBULIN HEAVY CHAIN
Yoshida et al. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene
AU764571B2 (en) 5' ESTs and encoded human proteins
AU2010263172B2 (en) Method of measuring adaptive immunity
AU758004B2 (en) Extended cDNAs for secreted proteins
Taubman et al. Cloning and characterization of mammalian myosin regulatory light chain (RLC) cDNA: the RLC gene is expressed in smooth, sarcomeric, and nonmuscle tissues.
WO2001057278A2 (en) Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human hela cells or other human cervical epithelial cells
JPH0654690A (ja) インターロイキン５レセプター
Yaspo et al. Model for a transcript map of human chromosome 21: isolation of new coding sequences from exon and enriched cDNA libraries
CN113388676B (zh) 一种用于检测结节性硬化症基因突变的探针集及其试剂盒
CN110241183B (zh) 一种fgfr融合基因的检测方法、试剂盒以及探针库
US6426186B1 (en) Bone remodeling genes
JP2002512049A (ja) 癌関連抗原をコードする単離核酸分子、それら抗原自身、及びそれらの利用方法
Chiannilkulchal et al. A primary expression map of the chromosome 15q15 region containing the recessive form of limb-girdle muscular dystrophy (LGMD2A) gene
WO1995027057A1 (en) GENE CODING FOR IgG-Fc-BINDING PROTEIN
Lepage et al. Molecular cloning and localization of the human GAX gene to 7p21
EP1012286B1 (en) Allelic variant of human stat3
JPH08266281A (ja) イガイ接着蛋白質遺伝子
CN114277146B (zh) 一种诊断腓骨肌萎缩症的探针组合、试剂盒及应用
JP2003532369A5 (https=)
WO2001009346A1 (en) Gene encoding novel adenylate kinase 3 (ak3)-like protein
CN108530541A (zh) 一种针对cd22的嵌合抗原受体的重组基因构建及其应用